Hikma Pharmaceuticals PLC HKMPY
$44.60
Last Updated: Aug 18, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
HKMPY Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Hikma Pharmaceuticals PLC is classified as halal.
HALAL
Report Source: undefined Quarter Report
Hikma Pharmaceuticals PLC. Stock Analysis HKMPY
United States Health Care Mid Cap Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Generics. The company supplies hospitals across its markets with generic and specialty injectable products, supported by its manufacturing facilities in the United States (US), Europe and Middle East/North Africa (MENA). The company supplies branded generic and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region. The company supplies oral, respiratory and other generic and specialty products to the North American retail market. Its manufacturing facilities in the US supply generic and specialty products to the US and Canada markets across a broad range of therapeutic areas, including respiratory, oncology and pain management.
Hikma Pharmaceuticals PLC (HKMPY) Chart
Financial Metrics & Statements of Hikma Pharmaceuticals PLC (HKMPY)
FAQ's for Hikma Pharmaceuticals PLC (HKMPY)
- As of August 2026, Hikma Pharmaceuticals PLC HKMPY is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Hikma Pharmaceuticals PLC using these criteria to determine its compliance status.
- Muslim investors may consider investing in Hikma Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Hikma Pharmaceuticals PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Hikma Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Hikma Pharmaceuticals PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Hikma Pharmaceuticals PLC (HKMPY)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
